TRIGL TRIGLYCERIDES 05171407190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-11-08 for TRIGL TRIGLYCERIDES 05171407190 manufactured by Roche Diagnostics.

Event Text Entries

[92609314] This event occurred in (b)(6). (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[92609315] The customer stated that they received an erroneous results for one severely lipemic patient sample tested for trigl triglycerides (trig) on a cobas 8000 c 702 module (c702). The erroneous result was not reported outside of the laboratory. The sample initially resulted as 173. 3 mg/dl. The sample was automatically diluted 1:50 and repeated on a different analyzer, resulting as 6863. 7 mg/dl. No adverse events were alleged to have occurred with the patient. The c702 analyzer serial number was asked for, but not provided. The reaction monitor of the first result showed a strong decrease in absorbance due to oxygen depletion during the assay reaction. It was confirmed that the customer was not using the most current version of the application parameters. In the most current test application version, the prozone check limit value was reduced in order to allow flagging of incorrect low triglyceride results of lipemic patient samples on the c702 analyzer. Upon review of calibration data, the last valid 2 point calibration was performed on (b)(6) 2017. From (b)(6) 2017 to (b)(6) 2017, successful blank calibrations were performed. Data was provided for one level of quality control and this was within range on the day of the event. Upon review of the alarm trace, several abnormal aspiration and sample short alarms could be observed from (b)(6) 2017 to (b)(6) 2017. The root cause is most likely related to the test application not being updated to the most current version. Based on the alarms received, a pre-analytic sample handling issue may also be a possible root cause.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1823260-2017-02557
MDR Report Key7009778
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-11-08
Date of Report2017-11-08
Date of Event2017-10-21
Date Mfgr Received2017-10-23
Date Added to Maude2017-11-08
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameTRIGL TRIGLYCERIDES
Generic NameTRIGLYCERIDES GPO WITHOUT FREE GLYCEROL
Product CodeCDT
Date Received2017-11-08
Model NumberNA
Catalog Number05171407190
Lot Number23846701
ID NumberNA
Device Expiration Date2018-05-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2017-11-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.